DUBLIN, November 30, 2021--(BUSINESS WIRE)--The "Proteomics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
The markets for proteomic technologies are difficult to estimate as they are not distinct but overlap with those of genomics, gene expression, high throughput screening, drug discovery and molecular diagnostics.
Markets for proteomic technologies are analyzed for the year 2020 and are projected to years 2024 and 2030. The largest expansion will be in bioinformatics and protein biochip technologies. Important areas of application are cancer and neurological disorders.
This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century.
The most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass spectrometry. Microanalytical protein characterization with multidimensional liquid chromatography/mass spectrometry improves the throughput and reliability of peptide mapping.
Matrix-Assisted Laser Desorption Mass Spectrometry (MALDI-MS) has become a widely used method for the determination of biomolecules including peptides, proteins. Functional proteomics technologies include yeast two-hybrid system for studying protein-protein interactions.
Establishing a proteomics platform in the industrial setting initially requires the implementation of a series of robotic systems to allow a high-throughput approach for analysis and identification of differences observed on 2D electrophoresis gels. Protein chips are also proving to be useful.
Proteomic technologies are now being integrated into the drug discovery process as complementary to genomic approaches. Toxicoproteomics, i.e. the evaluation of protein expression for the understanding of toxic events, is an important application of proteomics in preclinical drug safety. The use of bioinformatics is essential for analyzing the massive amount of data generated from both genomics and proteomics.
Proteomics is providing a better understanding of pathomechanisms of human diseases. Analysis of different levels of gene expression in healthy and diseased tissues by proteomic approaches is as important as the detection of mutations and polymorphisms at the genomic level and may be of more value in designing a rational therapy.
Protein distribution/characterization in body tissues and fluids, in health as well as in disease, is the basis of the use of proteomic technologies for molecular diagnostics. Proteomics will play an important role in the medicine of the future which will be personalized and will combine diagnostics with therapeutics. Important areas of application include cancer (oncoproteomics) and neurological disorders (neuroproteomics).
Potential markets for proteomic technologies
Bioinformatics markets for proteomics
Markets for protein separation technologies
Markets for 2D gel electrophoresis
Market trends in protein separation technolgies
Protein purification markets
Mass spectrometry markets
Markets for MALDI for drug discovery
Markets for nuclear magnetic resonance spectroscopy
Market for structure-based drug design
Markets for protein biomarkers
Markets for cell-based protein assays
Protein biochip markets
Western blot markets
Geographical distribution of proteomics technologies markets
Business and strategic considerations
Cost of protein structure determination
Opinion surveys of the scientist consumers of proteomic technologies
Opinions on mass spectrometry
Opinions on bioinformatics and proteomic databases
Systems for in vivo study of protein-protein interactions
Perceptions of the value of protein biochip/microfluidic systems
Small versus big companies
Expansion in proteomics according to area of application
Growth trends in cell-based protein assay market
Challenges for development of cell-based protein assays
Future trends and prospects of cell-based protein assays
Analysis of proteomics collaborations according to types of companies
Types of proteomic collaborations
Proteomics collaborations according to application areas
Analysis of proteomics collaborations: types of technologies
Collaborations based on protein biochip technology
Concluding remarks about proteomic collaborations
Market drivers in proteomics
Needs of the pharmaceutical industry
Need for outsourcing proteomic technologies
Funding of proteomic companies and research
Technical advances in proteomics
Changing trends in healthcare in future
Challenges facing proteomics
Magnitude and complexity of the task
Limitations of proteomics
Limitations of 2DGE
Limitations of mass spectrometry techniques
Complexity of the pharmaceutical proteomics
Unmet needs in proteomics
Key Topics Covered:
Part I: Technologies & Markets
1. Basics of Proteomics
2. Proteomic Technologies
3. Protein biochip technology
4. Bioinformatics in Relation to Proteomics
5. Research in Proteomics
6. Pharmaceutical Applications of Proteomics
7. Application of Proteomics in Human Healthcare
10. Proteomics Markets
11. Future of Proteomics
Part II: Companies
13. Companies involved in developing proteomics
For more information about this report visit https://www.researchandmarkets.com/r/wx7j0j
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005740/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900